1. 103995136 一种猪繁殖与呼吸综合征病毒胶体金快速检测试纸条
CN
25.01.2017
G01N 33/68 Loading...
G01N 33/68
Loading...
102014000249217
武汉中博生物股份有限公司
李建
G01N 33/68
Loading...
本发明公开了猪繁殖与呼吸综合征病毒胶体金快速检测试纸条。该试纸条包括：样品吸收垫、含有胶体金标记的猪繁殖与呼吸综合征病毒M蛋白单克隆抗体的玻璃纤维膜、有检测线T和对照线C的硝酸纤维素膜、吸水滤纸和底板；检测线T包被有猪繁殖与呼吸综合征病毒GP5蛋白单克隆抗体，对照线C包被有二抗IgG；样品吸收垫、玻璃纤维膜、硝酸纤维素膜和吸水滤纸依次相互搭接粘贴于底板上。本发明利用膜层析双抗体夹心法检测样本中猪繁殖与呼吸综合征病毒，其操作简单、方便、快捷，不需要特殊仪器设备和专业培训，易于推广，结果清晰易辨，适合基层，适合突发事件的大批量现场检测和流行病学调查，对猪繁殖与呼吸综合征病毒感染诊断起到辅助作用。
2. 104288290 一种用于治疗宠物体表真菌感染的喷剂及其制备方法
CN
04.01.2017
A61K 9/12 Loading...
A61K 9/12
Loading...
102014000580128
武汉中博绿亚生物科技有限公司
伍中杰
A61K 9/12
Loading...
本发明公开一种用于治疗宠物体表真菌感染的喷剂及其制备方法，旨在提供一种制备方法简单、使用方便、疗效好、安全性高的用于治疗宠物体表真菌感染的喷剂。其技术要点是：一方面，本发明提供一种用于治疗宠物体表真菌感染的喷剂，由下述重量份的组分组成：酒精65～95份，盐酸特比萘芬0.1～5份，氮酮0.1～5份，中药组合物的提取物5～20份，丁香酚0.1～5份；其中，所述的中药组合物由下述重量份的原料组成：蛇床子5～20份、大黄3～10份、山苍子2～8份、白鲜皮2～5份、地肤子3～7份。另一方，本发明还提供上述喷剂的制备方法。本发明属于动物医药技术领域。
3. 106172260 一种用于鱼类单殖吸虫的体外培养方法
CN
07.12.2016
A01K 67/033 Loading...
A01K 67/033
Loading...
102016000693624
武汉中博水产生物技术有限公司
张生元
A01K 67/033
Loading...
本发明属于水产生物技术领域，具体涉及了一种用于鱼类单殖吸虫的体外培养方法。所述体外培养方法包括如下步骤：(1)无菌条件下，将经传代培养的细胞重悬于第一培养基中，调整细胞密度后转接于培养皿中，置于第一培养条件下培养，待细胞贴壁后，弃去所述第一培养基，加入第二培养基，待用；(2)将从鱼体剥离的单殖吸虫重悬于第二培养基，然后转接于步骤(1)所述培养皿中，于第二培养条件下培养，获得在体外存活的鱼类单殖吸虫。本发明解决了单殖吸虫必须寄生在鱼鳃或幼鱼鳍条上，无法离体存活的问题，不会像传统的单殖吸虫病研究受到流行季节的限制，因此具有缩短单殖吸虫病新药创制研究周期的作用。
4. 106075427 1型禽腺病毒疫苗、蛋黄抗体的制备方法
CN
09.11.2016
A61K 39/235 Loading...
A61K 39/235
Loading...
201610506517.7
武汉中博生物股份有限公司
李晶梅
A61K 39/235
Loading...
本发明公开了一种1型禽腺病毒疫苗、蛋黄抗体的制备方法，属于兽用生物制品领域。本发明的1型禽腺病毒疫苗的制备方法包括1型禽腺病毒接种鸡胚肝细胞制备抗原、测定抗原的病毒含量、含量合格的抗原经灭活剂灭活、灭活检验合格的抗原与佐剂混合乳化制备疫苗等步骤。本发明的1型禽腺病毒蛋黄抗体的制备方法包括疫苗免疫产蛋鸡、收集高免蛋、提取抗体、测定效价等步骤。本发明制备的1型禽腺病毒疫苗具有抗原含量高、质量稳定等优点；本发明制备的1型禽腺病毒蛋黄抗体对1型禽腺病毒有很好的预防和治疗效果。
5. 106074592 一种提高犬免疫力的中西复方纳米微乳剂及制备方法
CN
09.11.2016
A61K 31/715 Loading...
A61K 31/715
Loading...
201610382098.0
武汉中博绿亚生物科技有限公司
伍中杰
A61K 31/715
Loading...
本发明公开了一种提高犬免疫力的中西复方纳米微乳剂，中药为植物多糖，包括黄芪多糖、灵芝多糖、熟地多糖、香茹多糖、山药多糖、枸杞多糖；所述的黄芪多糖、灵芝多糖、熟地多糖、香茹多糖、茯苓多糖、山药多糖、枸杞多糖的重量比例为：1～5：1～5：1～5：0.5～2：0.5～2：0.5～2。西药为：盐酸左旋咪唑，所占比例为0.1～0.2份。本发明的目的是提供一种适口性良好，吸收率高，提高犬免疫力的纳米微乳剂，本发明还提供该纳米微乳剂的制备方法。
6. 106070301 一种用于治疗犬蜱虫感染的复方喷剂及其制备方法
CN
09.11.2016
A01N 57/14 Loading...
A01N 57/14
Loading...
201610383293.5
武汉中博绿亚生物科技有限公司
伍中杰
A01N 57/14
Loading...
本发明公开了一种用于治疗犬蜱虫感染的复方喷剂，由以下重量份组分组成：酒精60～90份，辛硫磷0.1～1份，农药助剂2～10份，氰戊菊酯0.01～0.08份，纯水5～30份。本发明的目的是提供一种制备方法简单，使用方便，疗效好，安全性高的用于治疗犬蜱虫感染的喷剂，本发明还提供该喷剂的制备方法。
7. 105994112 一种应用于观赏鱼养殖水体水质的养护稳定制剂
CN
12.10.2016
A01K 63/04 Loading...
A01K 63/04
Loading...
201610382530.6
武汉中博绿亚生物科技有限公司
田彬
A01K 63/04
Loading...
本发明公开了一种应用于观赏鱼养殖水体水质的养护稳定制剂，包括如下重量组分：天然矿物质50～60份，过氧化钙15～20份，葡萄糖10～20份,维生素C5～10份。本发明的目的是提供一种天然、高效、毒副作用小、安全性高、无残留，能显著地提高观赏鱼养殖水体的调改养护能力，改良观赏鱼养殖水质，增强观赏鱼抗病能力，促进观赏鱼生长的观赏鱼养殖水体的养护稳定制剂。
8. 103349758 一种水产养殖动物保肝护肝的中药制剂及制备方法
CN
10.08.2016
A61K 36/9066 Loading...
A61K 36/9066
Loading...
102013000316666
武汉中博水产生物技术有限公司
喻运珍
A61K 36/9066
Loading...
一种水产养殖动物保肝护肝的中药制剂及制备方法，一种水产养殖动物保肝护肝的中药制剂，它由姜黄浸膏、玉米淀粉一定比例的原料制成，其步骤：A、取姜黄药材粉末，用500 mL 80%v/v乙醇回流提取；B、过滤提取液，合并，用旋转蒸发仪浓缩；C、转移至烧杯中，一定温度，加入玉米淀粉混合均匀；D、再置于烘箱中，一定温度下干燥；E、取出干燥药物过筛，得到了中药制剂。本发明保护水产动物肝脏不受或减轻损伤，避免了因肝脏损伤而引起并发其它疾病，减少了水产动物疾病的发生。植物源性药物，安全有效，该方法提取的姜黄素、总姜黄素含量高，配方合理，效果好，方法易行，操作方便，尤其适用于水产养殖中配合饲料的集约化、规模化养殖的需要。
9. 105833141 一种用于治疗犬蠕形螨体感染的中西复方的喷剂及其制备方法
CN
10.08.2016
A61K 36/904 Loading...
A61K 36/904
Loading...
102016000382100
武汉中博绿亚生物科技有限公司
伍中杰
A61K 36/904
Loading...
本发明公开了一种用于治疗犬蠕形螨体感染的中西复方的喷剂，由以下重量组分组成：酒精10～30份，双甲脒0.0125～0.025份，885农药助剂2～5份，中药组合物的提取物65～80份，丁香酚2～10份；其中：所述的中药组合物由下述重量份的原料经过提取得到：百部5～20份、荆芥3～10份、苍耳子5～10份、使君子5～10份、硫磺2～6份、苦楝子5－10份。本发明的目的是提供一种制备方法简单，使用方便，疗效好，安全性高的用于治疗犬蠕形螨感染的喷剂，本发明还提供该喷剂的制备方法。
10. 104232798 鸭甲型肝炎病毒检测与基因A型和C型鉴别的多重荧光定量PCR方法及试剂盒
CN
06.07.2016
C12Q 1/70 Loading...
C12Q 1/70
Loading...
201410510691.X
武汉中博生物股份有限公司
孙庆歌
C12Q 1/70
Loading...
本发明公开了一种鸭甲型肝炎病毒检测与基因A型和C型鉴别的多重荧光定量PCR方法及试剂盒，属于生物检测技术领域。本发明针对于DHAV 3D区域设计一对保守扩增引物（SEQ ID NO:1和2）和一条保守探针（SEQ ID NO:5），用于检测不同基因型的鸭甲型肝炎病毒；针对于DHAV 5’UTR设计一对特异性引物（SEQ ID NO:3和4）和两条特异性探针（SEQ ID NO:6和7），用于鉴别检测DHAV-A和DHAV-C。本发明具有良好的特异性、重复性和敏感性，操作方便、简单、快速，可用于科研及临床中DHAV的感染以及DHAV-A和DHAV-C 鉴别诊断，也可用于DHAV病原流行病学调查。
11. 105343112 一种非泼罗尼复方驱除宠物体表寄生虫的制剂及其制备方法
CN
24.02.2016
A61K 31/661 Loading...
A61K 31/661
Loading...
201510632809.0
武汉中博绿亚生物科技有限公司
刘高升
A61K 31/661
Loading...
本发明公开一种非泼罗尼复方驱除宠物体表寄生虫的制剂及其制备方法，旨在提供一种具有使用方便、疗效快、安全性高特点的非泼罗尼复方驱除宠物体表寄生虫的制剂。本发明的一种非泼罗尼复方驱除宠物体表寄生虫的制剂，它是由下述重量份的组分组成：酒精60～87份，非泼罗尼0.2～1.5份，精885农药增效助剂2～10份，辛硫磷0.3～1.5份，纯水5～30份；属于动物医药技术领域。
12. 105251030 一种用于宠物生活环境的可食用的祛味消毒剂及其制备方法
CN
20.01.2016
A61L 9/013 Loading...
A61L 9/013
Loading...
201510631763.0
武汉中博绿亚生物科技有限公司
刘高升
A61L 9/013
Loading...
本发明公开一种用于宠物生活环境的可食用的祛味消毒剂及其制备方法，旨在提供一种用于宠物生活环境的可食用的祛味消毒剂，该喷剂能快速消除宠物生活环境中的不良气味，杀灭环境中的微生物，给饲养者和宠物一个良好的生活环境。本发明的一种用于宠物生活环境的可食用的祛味消毒剂该祛味消毒剂，它是由下述重量份的组分组成：脂肪酸消毒剂0.1～0.8份，芳香剂0.1～1份，表面活性剂0.5～8份，食用酒精1～12份，纯水82～98份；属于动物医药技术领域。
13. 105146178 一种应用于观赏鱼养殖的抗应激制剂
CN
16.12.2015
A23K 1/18 Loading...
A23K 1/18
Loading...
201510560249.2
武汉中博绿亚生物科技有限公司
伍中杰
A23K 1/18
Loading...
本发明公开了一种应用于观赏鱼养殖的抗应激制剂，由下述重量组份的原料配制而成：抗应激物质2～8份，中药提取物2～8份，维生素E？6～14份，维生素C？6～14份，果糖15～25份，葡萄糖35～45份，其他辅料5～15份；所述中药提取物主要成分及重量含量为：20％～30％的板蓝根素，20％～30％的水杨酸，40％～55％的单宁酸。本发明的抗应激制剂天然、高效、毒副作用小、安全性高、无残留，能显著地提高观赏鱼抗应激能力，改良观赏鱼养殖水质，增强观赏鱼抗病能力，促进观赏鱼的生长。
14. 105106247 一种治疗宠物猫肠道问题的药剂及其制备方法
CN
02.12.2015
A61K 36/064 Loading...
A61K 36/064
Loading...
201510632384.3
武汉中博绿亚生物科技有限公司
刘高升
A61K 36/064
Loading...
本发明公开了一种治疗宠物猫肠道问题的药剂及其制备方法，它是由下述重量份的组分组成：枯草芽胞杆菌1～10份，地衣芽胞杆菌1～10份，饲用高活性干酵母1～5份，牛磺酸1～5份，胰酶1～5份，辅料70～95份；本发明的一种治疗宠物猫肠道问题的药剂的制备方法，依次包括下述步骤：1)按重量份分别称取各组分；2)将称取的辅料的三分之一，与其余组分物质搅拌混匀，得到混合物A；3)向混合物A中加入余下的辅料再混合均匀，得到混合物B；4)检测，分装，即得。利用本发明的一种治疗宠物猫肠道问题的药剂治疗宠物猫的肠道问题具有治疗效果好、副作用少的特点。
15. 104215762 Indirect ELISA method and kit for detecting serum 3-type duck hepatitis virus a antibody
CN
17.12.2014
G01N 33/576 Loading...
G01N 33/576
Loading...
201410507423.2
武汉中博生物股份有限公司
孙庆歌
G01N 33/576
Loading...
The invention discloses an indirect ELISA method and kit for detecting serum 3-type duck hepatitis virus a antibody and belongs to the technical field of serum antibody detection. The indirect ELISA method includes that serum 3-type duck hepatitis virus VP1 protein is utilized as an envelope antigen with the peridium quantity as 0.1-1mug per hole, HRP-mice anti-duck IgY is utilized as the HRP with the use concentration as 0.2-2mug/mL, and the coloration time is 10 minutes. The kit comprises a VP1 protein antigen envelope board, the HRP-mice anti-duck IgY, sample diluent, a scrubbing solution, TMB solutions A and B and a stop solution. The method and the kit can be used for detecting the serum 3-type duck hepatitis virus a antibody in duck serum and duck egg yolk, and the serum does not have cross reaction with positive serum of other viruses. Compared with a traditional neutral reaction detection method, the method has the advantage of being convenient and accurate.
16. 203838160 猪伪狂犬病毒gB和gE抗体的ELISA检测试剂盒
CN
17.09.2014
G01N 33/68 Loading...
G01N 33/68
Loading...
201420110907.9
武汉中博生物股份有限公司
廖园园
G01N 33/68
Loading...
本实用新型公开了一种猪伪狂犬病毒gB和gE抗体的ELISA检测试剂盒。该试剂盒有一个盒体，盒体内设有抗原包被反应板和操作说明书存放槽及9个孔槽；各槽中分别放置抗原包被反应板、说明书，装有gB抗体阳性对照液、gE抗体阳性对照液、gB和gE抗体阴性对照液、样品稀释液、酶结合物、浓缩洗涤液、酶底物A溶液、酶底物B溶液、终止液的试剂瓶。抗原包被反应板分为检测区Ⅰ和检测区Ⅱ，分别包被gB和gE蛋白抗原。本实用新型可同时批量检测出待检样品是否含有猪伪狂犬病毒gB和gE抗体，用于PRV野毒感染及疫苗免疫的鉴别诊断和评估PRV疫苗的免疫效果。具有灵敏度高、特异性好、快速检测大批量样品等优点。
17. 203772871 猪圆环病毒2型和猪蓝耳病毒IgM抗体的胶体金免疫层析检测试纸
CN
13.08.2014
G01N 33/577 Loading...
G01N 33/577
Loading...
201420110224.3
武汉中博生物股份有限公司
廖园园
G01N 33/577
Loading...
本实用新型公开了一种猪圆环病毒2型和猪蓝耳病毒IgM抗体的胶体金免疫层析检测试纸。该试纸包括样品吸收区、金标探针区、固相化抗原及抗体区和吸水区和支撑板，样品吸收区、金标探针区、固相化抗原抗体区和吸水区铺设在支撑板上并依次相互部分重叠；金标探针区包被胶体金标记的小鼠抗猪IgM单抗；固相化抗原及抗体区上有检测线T1、T2和对照线C，检测线T1、T2分别包被猪圆环病毒2型Cap蛋白和猪蓝耳病毒N蛋白，对照线C包被羊抗小鼠IgG抗体。本实用新型检测快速，准确率高、特异性强，携带、操作方便，可同时检测猪圆环病毒2型和猪蓝耳病毒IgM抗体，适合早期感染检测；其常温下即可保存，保存期达2年，且检测重复性好。
18. 103808927 Enzyme linked immunosorbent assay kit for detecting porcine reproductive and respiratory syndrome virus
CN
21.05.2014
G01N 33/569 Loading...
G01N 33/569
Loading...
201410039309.1
武汉中博生物股份有限公司
李建
G01N 33/569
Loading...
The invention discloses an enzyme linked immunosorbent assay kit for detecting porcine reproductive and respiratory syndrome virus, which belongs to the field of animal virus disease monitoring and diagnostic reagents. The kit comprises an elisa plate of a polyclonal antibody for coating an anti-porcine reproductive and respiratory syndrome virus, a biotin labeled monoclonal antibody of the porcine reproductive and respiratory syndrome virus, enzyme labeling streptavidin, positive control, negative control, a TMB developing liquid, a stop buffer, a scrubbing solution and a diluent. The kit is not only used for identifying more virus antigenic epitope by using polyclonal antibodies, but also marking monoclonal antibodies by using biotin, and the sensitivity of the kit is further improved through the signal amplification function of the enzyme labeling streptavidin. Besides, the kit has no cross reaction with porcine parvovirus, pig pseudorabies virus, porcine circovirus and swine fever virus, is good in repeatability, and is applicable to rapid diagnosis and research on porcine reproductive and respiratory syndrome virus infection.
19. 103760365 BAS-ELISA kit for detecting hog cholera virus Erns and E2 antigen
CN
30.04.2014
G01N 33/68 Loading...
G01N 33/68
Loading...
201410040870.1
武汉中博生物股份有限公司
李建
G01N 33/68
Loading...
The invention discloses a BAS-ELISA kit for detecting hog cholera virus Erns and E2 antigen, and belongs to the field of biological technologies and diagnosis and research of animal-borne diseases. The kit comprises an ELISA plate coated with a CSFV-Erns monoclonal antibody and a resistant-CSFV-E2 monoclonal antibody, a sample diluent, CSFV positive control and CSFV negative control, a scrubbing solution, a biotinylation rabbit-resistant CSFV-Erns polyclonal antibody and a biotinylation rabbit-resistant CSFV-E2 polyclonal antibody mixed solution, ELISA streptavidin, an enzyme developing substrate and a stop solution, wherein the two monoclonal antibodies and corresponding polyclonal antibodies have different epitopes. The kit adopts a biotin-avidin detecting system, and implements the combined detection for the hog cholera virus Erns and E2 protein, so that the sensitivity, specificity and repeatability in the detection of the hog cholera virus are greatly improved; the kit can be applied to the diagnosis and research of the hog cholera.
20. 103689284 Organic detritus cenobium bait for hypophthalmichthys nobilis and preparation method of bait
CN
02.04.2014
A23K 1/18 Loading...
A23K 1/18
Loading...
201310697868.7
武汉中博水产生物技术有限公司
艾桃山
A23K 1/18
Loading...
The invention discloses organic detritus cenobium bait for hypophthalmichthys nobilis and a preparation method of the bait, and relates to the technical field of fishing feeds. The bait comprises the following components in percentage by weight: 45-75% of fermented chicken manure, 9-21% of fermented rapeseed meal, 2-8% of chlorella powder, 2-8% of brewer grain, 0.6-1.4% of algae growth prompting microelements, 2-6% of a phagostimulant and 4-16% of a premix. The preparation method of the product comprises the following steps: fermenting, drying and crushing the chicken manure and the rapeseed meal, and mixing the prepared fermented chicken manure, fermented rapeseed meal and other components so as to obtain the bait. The invention aims at providing the organic detritus cenobium bait for the hypophthalmichthys nobilis and the preparation method of the bait, and by adopting the bait, not only is the acre yield of the hypophthalmichthys nobilis increased, but also the secondary pollution on aquatic water is reduced.
21. 103601302 Compound bacillus subtilis sustained-release tablet
CN
26.02.2014
C02F 3/34 Loading...
C02F 3/34
Loading...
201310651264.9
武汉中博水产生物技术有限公司
艾桃山
C02F 3/34
Loading...
Relating to the technical field of water environment improvement and repair in aquaculture, the invention provides a compound bacillus subtilis sustained-release tablet, which comprises, by weight: 2-9% of bacillus subtilis raw powder, 73-96% of sodium percarbonate, 1-10% of a sustained release agent, and 1-8% of a stabilizer. The invention aims to provide the compound bacillus subtilis sustained-release tablet. The product has a significant improvement effect on the culture water environment, is convenient to use, and avoids the problem of culture water oxygen deficiency.
22. 103555680 PRRSV (porcine reproductive and respiratory syndrome virus) virus-like particles with immunogenicity as well as preparation and application thereof
CN
05.02.2014
C12N 7/01 Loading...
C12N 7/01
Loading...
201310538271.8
武汉中博生物股份有限公司
杨雷
C12N 7/01
Loading...
The invention discloses PRRSV (porcine reproductive and respiratory syndrome virus) virus-like particles with immunogenicity as well as preparation and application thereof, and belongs to the technical field of agricultural veterinary biology. The preparation comprises the following steps: cloning coding sequences of N protein and GP5 protein of PRRSV into rod granules to obtain recombinant rod granules; infecting the recombined rod granules on insect cells, culturing the transfected insect cells to obtain recombinant baculovirus. The N protein and GP5 protein are expressed by adopting the recombinant baculovirus infected insect cells, protein with better steric configuration can be obtained, and PRRSV virus-like particles can be automatically assembled. The virus-like particles with high immunogenicity can be used for preparing vaccine for preventing infection of PRRSV. The PRRSV virus-like particles have high immune protective rate, can produce attacking protection on PRRSV virulent strain, can be safer and more effective, and do not have the risk of virulence return.
23. 103509877 Fluorescence quantitative PCR kit used for detecting PRV, and application thereof
CN
15.01.2014
C12Q 1/70 Loading...
C12Q 1/70
Loading...
201210200972.6
武汉中博生物股份有限公司
薛霜
C12Q 1/70
Loading...
The invention relates to a fluorescence quantitative PCR rapid detection kit used for specifically detecting pig pseudorabies virus (PRV) infection, and an application thereof. The kit comprises a specific primer pair used for amplifying PRV gE gene conserved region, and a specific TaqMan fluorescent-labeled probe. An upstream primer sequence of the specific primer pair is 5'-GAGGACGACGGGCTGTAC-3', and a downstream primer sequence of the specific primer pair is 5'-GGACATCAACAGGCGGTTG-3'. The sequence of the TaqMan probe is 5'-TGGGTCCATTCGTCACTTCCG-3'. The 5' end of the TaqMan probe is labeled with a fluorescent reporter group FAM. The 3' end of the TaqMan probe is labeled with a fluorescence quenching group BHQ1 which is not intrinsically fluorescent. The kit can be used for rapid qualitative and quantitative detections of PRV infection, and can be used in identification detections of PRV gE gene-deleted vaccine strains and/or PRV wild strains.
24. 103509838 High expression production process and extraction method of piglet escherichia coli K88, K99 and 987P cilium antigens
CN
15.01.2014
C12P 21/02 Loading...
C12P 21/02
Loading...
201310465436.3
武汉中博生物股份有限公司
熊媛媛
C12P 21/02
Loading...
The invention relates to a high expression production process and an extraction method for piglet escherichia coli K88, K99 and 987P cilium antigens. The production process is characterized in that glucose and peptone are fed in the culture process under a certain condition of temperature, stirring speed, ventilation volume and pH value, so as to obtain the escherichia coli with high expression cilium antigens, wherein the peptone is preferably tryptone. According to the production process, the escherichia coli with high expression K88, K99 and 987P cilium antigens can be obtained through dynamically feeding the glucose and the peptone under a certain condition of temperature, stirring speed, ventilation volume and pH value, the culture medium is low in cost, the fermentation process is simple and easy, and the solid foundation is laid for industrial production of piglet yellow scour vaccines.
25. 103399154 Test paper for colloidal gold immunochromatograohic assay of IgG (immunoglobulin G) antibody of dog anti-rabies virus and preparation method of test paper
CN
20.11.2013
G01N 33/577 Loading...
G01N 33/577
Loading...
201310323055.1
武汉中博生物股份有限公司
廖园园
G01N 33/577
Loading...
The invention discloses a piece of test paper for colloidal gold immunochromatograohic assay of an IgG (immunoglobulin G) antibody of dog anti-rabies virus and a preparation method of the test paper. The test paper comprises a sample absorbing region, a gold-labeled probe region, a solid-phase antibody region, a water absorbing region and a supporting plate, wherein the sample absorbing region, the gold-labeled probe region, the solid-phase antibody region and the water absorbing region are laid on the supporting plate and are partially overlapped in sequence; the sample absorbing region is coated with rabies virus antigen; the gold-labeled probe region is coated with a gold-labeled probe 1 and a gold-labeled probe 2 which are a monoclonal antibody of the colloidal gold-labeled rabies virus and rabbit IgG respectively; the solid-phase antibody region has a control line C1 (coated with a goat anti-rabbit IgG antibody), a testing line T (coated with a goat anti-dog IgG antibody), a control line C2 (coated with a goat anti-rabbit IgG antibody) and a control line C3 (coated with a goat anti-mouse IgG antibody). The test paper disclosed by the invention has the advantages that the test is fast, the accuracy rate is high, the specificity is strong, the test paper is simple and convenient to carry and operate, and the level of the rabies virus antibody is judged according to the color depths of the control lines.
26. 103308684 一种猪伪狂犬病毒IgM抗体ELISA检测试剂盒
CN
18.09.2013
G01N 33/577 Loading...
G01N 33/577
Loading...
201210066248.9
武汉中博生物股份有限公司
廖园园
G01N 33/577
Loading...
本发明涉及一种猪伪狂犬病毒IgM抗体ELISA检测试剂盒及其制备方法和其应用。本发明的猪伪狂犬病毒IgM抗体ELISA检测试剂盒，所述检测试剂盒含有：包被猪IgM单克隆抗体的酶标板、封闭液、样品稀释液、检测用抗原、酶结合物、浓缩洗涤液、酶底物A溶液、酶底物B溶液和终止液，其中，所述的检测用抗原由纯化的猪伪狂犬病毒gE蛋白、结构蛋白gB和结构蛋白gD组成，所述的酶结合物为辣根过氧化物酶-抗gE、gB或gD蛋白抗体酶结合物。本发明试剂盒的特异性达100％，灵敏度为1∶640，可用于猪群伪狂犬病毒感染的早期诊断。
27. 103308688 猪圆环病毒2型IgM抗体ELISA检测试剂盒及制备方法
CN
18.09.2013
G01N 33/68 Loading...
G01N 33/68
Loading...
201210066225.8
武汉中博生物股份有限公司
廖园园
G01N 33/68
Loading...
本发明涉及一种猪圆环病毒2型IgM抗体ELISA检测试剂盒及其制备方法和其应用。本发明的猪圆环病毒2型IgM抗体ELISA检测试剂盒含有：包被猪IgM单克隆抗体的酶标板、封闭液、样品稀释液、检测用抗原、酶结合物、浓缩洗涤液、酶底物A溶液、酶底物B溶液和终止液，其中，所述检测用抗原为纯化的猪圆环病毒2型核衣壳蛋白(PCV2-Cap蛋白)抗原，所述的酶结合物为辣根过氧化物酶-抗Cap蛋白抗体酶结合物。本发明试剂盒的特异性达100％，灵敏度高达1∶800，可用于猪群PCV2感染的早期诊断。
28. 203144082 冻干机配套装置
CN
21.08.2013
B67C 3/02 Loading...
B67C 3/02
Loading...
201320027018.1
武汉中博生物股份有限公司
李晶梅
B67C 3/02
Loading...
本实用新型公开了一种冻干机配套装置，包括取样端、分装端、样品通路和动力系统，取样端、分装端、样品通路依次相连通，样品通路接入动力系统。本装置的半自动分装方式降低了分装工作强度，提高了分装效率和精度；本装置还可实现整体进柜、整体出柜，避免了西林瓶的逐个摆放，简化了分装前的准备工作。本装置可用作中试和小型冻干机的配套装置，适用于生物制品、制药行业。
29. 103191414 一种宠物快速吸收的液体钙及其制备方法
CN
10.07.2013
A61K 38/17 Loading...
A61K 38/17
Loading...
201310106552.6
武汉中博绿亚生物科技有限公司
刘高升
A61K 38/17
Loading...
本发明公开一种宠物快速吸收的液体钙及其制备方法，旨在提供一种高溶解，高吸收，高留存的宠物快速吸收的液体钙；其技术要点是：该宠物快速吸收的液体钙，由下述重量份的组分组成：氨基酸螯合钙10～20份，酪蛋白磷酸肽1～10份，维生素D30.01～0.1份，瓜尔胶0.5～2份，阿拉伯胶0.5～2份，大豆卵磷脂1～8份，柠檬酸0.1～1份，苯甲酸钠0.1～1份，香精0.01～0.1份，蒸馏水60～90份；属于动物医药技术领域。
30. 202925027 一种大规模封闭式原代细胞制备装置
CN
08.05.2013
C12M 3/00 Loading...
C12M 3/00
Loading...
201220465748.5
武汉中博生物股份有限公司
李晶梅
C12M 3/00
Loading...
一种大规模封闭式原代细胞制备装置，包括组织消化单元⑴、细胞分散单元⑴、细胞过滤单元⑶、细胞盛装单元⑷以及动力系统，各单元之间、各单元内部通过硅胶管、多通管相连通。其优点在于：本装置使用管线连接各个功能单元，使用空气过滤器保证进入体系的气体是无菌的，连为一体的装置使得原代细胞的制备全程是相对密闭的，减少了内容物与外环境接触的次数，比传统原代细胞制备的操作方法降低了污染几率；降低了人工操作的劳动强度，比传统操作方法提高了工作效率，放大了生产规模；使用了自体循环，模拟吹打法制备原代细胞，对细胞的损伤小，所获细胞的活力高。本装置可用于生物制品行业大规模制备原代细胞。
31. 103033622 猪圆环病毒2型ELISA抗原检测试剂盒及其制备方法和其应用
CN
10.04.2013
C12N 15/866 Loading...
C12N 15/866
Loading...
201210356552.7
武汉中博生物股份有限公司
廖园园
C12N 15/866
Loading...
本发明涉及一种猪圆环病毒2型ELISA抗原检测试剂盒及其制备方法和其应用。其中，所述检测试剂盒含有：包被抗PCV2-Cap蛋白的多克隆抗体的酶标板、封闭液、样品稀释液、抗原标准品、HRP标记的抗PCV2-Cap蛋白的单克隆抗体的二抗、浓缩洗涤液、酶底物A溶液、酶底物B溶液和终止液，其中，所述抗原标准品为纯化的重组猪圆环病毒2型核衣壳蛋白（PCV2-Cap蛋白）。本发明试剂盒的特异性达100%，灵敏度高达4ng/ml，可用于猪群PCV2抗原检测和PCV2疫苗产品的定量检测。
32. 103007289 鸭病毒性肝炎活疫苗用耐热保护剂及其制备方法和应用
CN
03.04.2013
A61K 47/42 Loading...
A61K 47/42
Loading...
201210448030.X
上海创宏生物科技有限公司
苏敬良
A61K 47/42
Loading...
本发明涉及鸭病毒性肝炎活疫苗用耐热保护剂及其制备方法和应用，将冻干保护剂基质按一定的比例混合、配制，将保护剂分别进行无菌处理，对可以进行高压灭菌的保护剂组份溶于双蒸水中，108～121℃灭菌15～30分钟；将不耐高压灭菌的保护剂组份按配比溶于双蒸水中用0.22μm的滤膜除菌，再将两者混合成为耐热保护剂，然后将该耐热保护剂和鸭病毒性肝炎病毒液进行1∶1～1.2混合，采用相应的冻干曲线冻干，与现有技术相比，本发明为鸭病毒性肝炎弱毒活疫苗的研制提供了很好的资源，克服国产疫苗保存工艺落后现状，在2～8℃条件下保存24个月，疫苗效价均保持在每羽份≥106.0EID50。
33. 102988462 一种防治水产动物寄生虫的中药制剂及制备方法和应用
CN
27.03.2013
A61K 36/47 Loading...
A61K 36/47
Loading...
201210554516.1
武汉中博水产生物技术有限公司
喻运珍
A61K 36/47
Loading...
本发明公开了一种防治水产动物寄生虫的中药制剂及制备方法和应用，一种防治水产动物体外寄生虫病的中药制剂，其制备步骤是：1）狼毒大戟用80%乙醇进行索氏提取，收集提取液；2）用石油醚萃取；3）用乙酸乙酯萃取，得固体残渣；4）固体残渣用乙醇洗脱，挥发溶剂得到狼毒大戟乙酸乙酯提取物；5）称取3-10g步骤4）中得到的提取物，用丙酮完全溶解后，加5-10g的乳化剂和1-2g的稳定剂，丙酮定容100ml。该方法将狼毒大戟杀虫活性成分分离出来，方法易行，操作方便，狼毒大戟提取物对鲫鱼和草鱼的安全浓度分别为2.61ppm和2.38ppm，对鱼类是比较安全的，可以应用于水产养殖生产中水产动物体外寄生虫病，适用于集约化、规模化水产养殖的需要。
34. 102936612 一种应用生物反应器制备抗犬瘟热病毒单克隆抗体的方法
CN
20.02.2013
C12P 21/08 Loading...
C12P 21/08
Loading...
201210322356.8
武汉中博生物股份有限公司
李伟
C12P 21/08
Loading...
本发明涉及一种应用生物反应器制备抗犬瘟热病毒单克隆抗体的方法，其特征在于，包括如下步骤：1）将分泌抗犬瘟热病毒单克隆抗体的杂交瘤细胞株进行无血清悬浮适应培养；2）在生物反应器内分两阶段培养所述杂交瘤细胞；3）收获培养上清液；4）超滤、冻干，制得成品。本发明应用生物反应器悬浮培养生产单克隆抗体的方法，克服了动物体内制备抗犬瘟热病毒单克隆抗体方法中所存在的产品杂蛋白含量高、质量不稳定、批间差大等缺陷，并具有培养基成分明确、方法和过程可控、抗体纯度高、操作简便、生产效率高等优点。
35. 102925486 一种猪圆环病毒2型亚单位疫苗及其制备方法和其应用
CN
13.02.2013
C12N 15/866 Loading...
C12N 15/866
Loading...
201210270504.6
武汉中博生物股份有限公司
朱薇
C12N 15/866
Loading...
本发明涉及一种猪圆环病毒2型亚单位疫苗及其制备方法和其应用，所述重组杆状病毒含有双启动子（多角体蛋白启动子和P10启动子），可表达双拷贝的Cap蛋白编码基因，显著提高了蛋白的表达效率。并且，插入的外源基因所表达的Cap蛋白不含多余序列，能有效形成病毒样颗粒（VLPs），提高了表达蛋白的免疫原性，且生产的抗原含量高。本发明的猪圆环病毒2型亚单位疫苗，显著提高了猪圆环病毒2型亚单位疫苗的蛋白产率及质量，所制得的疫苗组合物具有免疫效果稳定、持久、安全性高等优点。
36. 102925355 一种鼓浪式细胞生物反应器
CN
13.02.2013
C12M 3/00 Loading...
C12M 3/00
Loading...
201210464398.5
武汉中博生物股份有限公司
李伟
C12M 3/00
Loading...
一种鼓浪式细胞生物反应器，包括由一斜边为弧线的倒直角三角形沿一直角边旋转而成的倒锥形鼓浪搅拌桨⑺。所述倒锥形鼓浪搅拌桨⑺的弧线斜边包括但不限于圆弧和椭圆弧。其优点在于：结构简单、适用性广、可扩展性强；可同时用于纯悬浮细胞和微载体贴壁细胞的培养，并可根据不同细胞培养方式灵活调整桨的结构和运动方式；本发明鼓浪式生物反应器易于放大，通过改变搅拌桨及罐体尺寸，很容易实现动物细胞硬件尺度上的放大培养，为大规模培养动物细胞并工业化生产生物及组织制品创造了条件。
37. 102517331 一种猪圆环病毒2型亚单位疫苗及其制备方法和其应用
CN
27.06.2012
C12N 15/866 Loading...
C12N 15/866
Loading...
201110440750.7
武汉中博生物股份有限公司
朱薇
C12N 15/866
Loading...
本发明涉及一种猪圆环病毒2型亚单位疫苗及其制备方法和其应用，所述重组杆状病毒含有双启动子(多角体蛋白启动子和P10启动子)，可表达双拷贝的Cap蛋白编码基因，显著提高了蛋白的表达效率；并且，插入的外源基因所表达的Cap蛋白不含多余序列，能有效形成病毒样颗粒(VLPs)，提高了表达蛋白的免疫原性，且生产的抗原含量高；本发明的猪圆环病毒2型亚单位疫苗，显著提高了猪圆环病毒2型亚单位疫苗的病毒蛋白产率及质量，所制得的疫苗组合物具有免疫效果稳定、持久、安全性高等优点。
38. 102409112 一种用于检测NDV的荧光定量RT-PCR试剂盒及其用途
CN
11.04.2012
C12Q 1/70 Loading...
C12Q 1/70
Loading...
201110424468.X
武汉中博生物股份有限公司
薛霜
C12Q 1/70
Loading...
本发明提供了一组用于检测各亚型的新城疫病毒(NDV)的特异性核苷酸序列，以及一种用于检测NDV感染的荧光定量RT-PCR快速检测试剂盒。该试剂盒用于临床及科研领域，包括对NDV感染进行快速定性定量检测，以及对鸡群、禽类产品和制品中NDV的监测。本发明还提供了不用于诊断目的的用于检测鸡新城疫病毒感染的荧光定量RT-PCR方法。
39. 102293831 Compound pulvis for controlling saprolegniasis of aquatic animal and preparation method thereof
CN
28.12.2011
A61K 36/708 Loading...
A61K 36/708
Loading...
201110139065.0
Wuhan Chopper Fishery Bio-Tech Co., Ltd.
Yu Yunzhen
A61K 36/708
Loading...
The invention discloses a compound pulvis for controlling saprolegniasis of aquatic animals and a preparation method thereof. The compound pulvis is prepared from Chinese gall, rheum officinale, bronopol and dispersant in a certain weight percentage. The preparation method comprises steps of: A. drying the Chinese gall and the rheum officinale decoction pieces; B. crushing and sieving the Chinese gall and the rheum officinale respectively; C. weighing the Chinese gall and the rheum officinale according to the proportion and mixing; weighing the traditional Chinese medicine mixture, preblending with bronopol; weighing the preblended mixture according to an equivalent progressive increase method, and mixing with the dispersant; well mixing and subpackaging to obtain the compound pulvis. The method is practical and easily operated; the compound pulvis has a reasonable formula, usage convenience, low costs, substantial effects, and no toxic or side effects; the bronopol is widely used in water treatment, medicine, pesticide, cosmetic and washing agent, and has interacted ingredients and effects of quick-acting, slow action and simultaneous treatment of principal and subordinate symptoms; the dispersant in the composition improves medicament leachability and can substantially improve curative effect.
40. 102268488 Fluorescence quantitative reverse transcription-polymerase chain reaction (RT-PCR) detection kit for detecting bovine viral diarrhea virus and application of kit
CN
07.12.2011
C12Q 1/70 Loading...
C12Q 1/70
Loading...
201110207848.8
Wuhan Chopper Biology Co., Ltd.
Xue Shuang
C12Q 1/70
Loading...
The invention provides a fluorescence quantitative reverse transcription-polymerase chain reaction (RT-PCR) detection kit for detecting bovine viral diarrhea virus (BVDV) and application of the kit. The kit is used for the field of clinic and scientific research, including quick quantitative detection of BVDV infection and BVDV pollution monitoring of biological products such as bovine serum, bovine serum albumin and bovine testicle cell derived hog cholera lapinized virus vaccines and the like. The invention also provides a non-diagnostic fluorescence quantitative RT-PCR method for detecting BVDV infection.
41. 102183650 Porcine circovirus type 2 (PCV2) enzyme-linked immuno sorbent assay (ELISA) antibody detection kit
CN
14.09.2011
G01N 33/577 Loading...
G01N 33/577
Loading...
201110038284.X
Wuhan Chopper Biology Co., Ltd.
Zhu Wei
G01N 33/577
Loading...
The invention relates to a porcine circovirus type 2 (PCV2) enzyme-linked immuno sorbent assay (ELISA) antibody detection kit. The detection kit contains a PCV2-Cap monoclonal antibody and PCV2-Cap pre-coated enzyme-labeled plate, blocking solution, sample diluent, an enzyme compound, washing concentrate, enzyme substrate solution and stop solution, wherein the nucleocapsid protein is purified Cap protein for forming virus-like particles. The specificity of the kit reaches 100 percent; and the sensitivity is 1:800. The kit is use for monitoring the porcine PCV2 antibody level, and definitely acquires the porcine immune level or infection state.
42. 102166362 Porcine reproductive and respiratory syndrome live vaccine heat-resistant freeze-drying protective agent and preparation method thereof
CN
31.08.2011
A61K 47/42 Loading...
A61K 47/42
Loading...
201110091987.9
Wuhan Chopper Biology Co., Ltd.
Yang Lei
A61K 47/42
Loading...
The invention relates to a porcine reproductive and respiratory syndrome live vaccine heat-resistant freeze-drying protective agent and a preparation method thereof. The heat-resistant freeze-drying protective agent is mixed by the raw materials based on weight percentage: 1-2% of gelatin, 4-6% of trehalose, 1-2% of tryptone, 1-2% of trypticase, 1-2% of polyvinylpyrrolidone, 0.164% of dipotassium phosphate, 0.052% of monopotassium phosphate, 1% of sorbic alcohol, 1% of sodium glutamate, 1% of arginine salt and the balance of water. The preparation method comprises the steps of: preparing the materials into two mixed solution, respectively preparing in a mixing way by means of degerming to prepare a heat-resistant freeze-drying protective agent, mixing according to the proportion of the protective agent to the virus-resistant raw material as 1:1, performing split charging, and drying in a freezing way. Before drying in a freezing way, the virus loss rate is low, a freeze-drying product is high in ageing-resistant degree, and the virus is invariable in content after the freeze-drying product is preserved at the temperature of 2-8 DGE C for 24 months. After the invention is used, the technical neck bottle that the porcine reproductive and respiratory syndrome live vaccine can be preserved and transported under the condition of -15 DEG C is solved.
43. 102133398 Method for industrially producing animal influenza vaccine by using bioreactor
CN
27.07.2011
A61K 39/145 Loading...
A61K 39/145
Loading...
201010282155.0
Wuhan Chopper Biology Co., Ltd.
Li Jingmei
A61K 39/145
Loading...
The invention relates to a method for industrially producing animal influenza vaccine by using a bioreactor, comprising the following steps of: (1) adding Vero or MDCK cells in the sterilized bioreactor containing a micro-carrier and culturing in a serum-including culture medium; (2) replacing the culture medium including serum in the bioreactor by a serum-free culture medium which includes pancreatin; (3) inoculating animal influenza virus to culture continuously; (4) harvesting to obtain a cell-cultured influenza virus stock solution when the pathological change of the cells is up to 80%; and (5) hyper-filtering, concentrating and inactivating the influenza virus stock solution and then adding an adjuvant to obtain the influenza inactivated vaccine. The method provided by the invention has the advantages of controllable process parameters, high cell density, high virus titer, high production efficiency, low labor intensity and the like. The influenza vaccine produced by the invention has good security, stable and reliable quality, small side reaction and high immune effect and has a better immune protection function for the attack of the influenza virus.
44. 102038947 Method for industrially producing animal rabies vaccine by utilizing bioreactor
CN
04.05.2011
A61K 39/245 Loading...
A61K 39/245
Loading...
201010282153.1
Wuhan Chopper Biology Co., Ltd.
Liu Hanping
A61K 39/245
Loading...
The invention provides a method for industrially producing an animal rabies vaccine by utilizing a bioreactor, comprising the following steps of: (1) sterilizing a micro-carrier and the bioreactor, adding a cell growth solution, inoculating Vero cells for culturing, inoculating rabies viruses after the cell on the micro-carrier forms a compact single layer, and continuously culturing to propagate the viruses; (2) inoculating for 18h and then continuously harvesting a virus solution; (3) carrying out ultrafiltration concentration and virus inactivation on the harvested virus solution; and (4) purifying and inactivating the viruses through a column chromatography method to prepare the vaccine. In the invention, the high density culturing of the cells is carried out by utilizing a bioreactor micro-carrier culturing technology to produce the animal rabies vaccine. Compared with the traditional rotating bottle production method, the automation control degree is high, the production can be monitored in real time, the labor power and the cost are reduced, the production land is less, the scale is easy to expand, the produced virus titer is high, the difference among batches is less, the product quality is stable, and the side reaction is less.
45. 102038944 Method for industrially producing swine fever live vaccine by using bioreactor
CN
04.05.2011
A61K 39/187 Loading...
A61K 39/187
Loading...
201010282143.8
Wuhan Chopper Biology Co., Ltd.
Qi Shihua
A61K 39/187
Loading...
The invention relates to a method for industrially producing a swine fever live vaccine by using a bioreactor. The method comprises the following steps of: (1) sterilizing a microcarrier and the bioreactor, adding cell growth solution, inoculating cells for vaccine production, culturing the cells, and after the cells on the microcarrier form a compact monolayer, discarding the cell growth solution, adding virus maintenance solution and inoculating swine fever virus, and continuously culturing to allow the virus to reproduce; and (2) after the virus is inoculated for 18 hours, continuously obtaining virus culture solution, storing the virus culture solution at the temperature of below -15 DEG C, mixing the virus culture solution, and adding a cryoprotectant to prepare the swine fever live vaccine. The method has the advantages of high controllability of process parameters, high cell culture density, high virus titer, high vaccine safety, stable and reliable quality, high production efficiency and the like.
46. 102038945 Method for industrially producing swine parvovirus vaccine by utilizing bioreactor
CN
04.05.2011
A61K 39/23 Loading...
A61K 39/23
Loading...
201010282134.9
Wuhan Chopper Biology Co., Ltd.
Qin Honggang
A61K 39/23
Loading...
The invention provides a method for industrially producing a swine parvovirus vaccine by utilizing a bioreactor, comprising the following steps of: (1) sterilizing a micro-carrier and the bioreactor, adding a cell growth solution, inoculating, preparing the vaccine and culturing with cells, inoculating a swine parvovirus after the cell on the micro-carrier forms a compact single layer, and continuously culturing to propagate the virus; (2) stopping culturing until the cytopathy reaches more than 80%, and harvesting a virus solution; (3) carrying out ultrafiltration concentration and virus inactivation on the harvested virus solution; and (4) purifying and inactivating the virus through a column chromatography method to prepare the vaccine. The invention has the advantages of favorable controllability of processing parameters, high cell density and virus titer, favorable vaccine safety, stable and reliable quality, high production efficiency, and the like.
47. 102038942 Method for industrially producing porcine reproductive and respiratory syndrome (PRRS) vaccines by utilizing bioreactor
CN
04.05.2011
A61K 39/12 Loading...
A61K 39/12
Loading...
201010282151.2
Wuhan Chopper Biology Co., Ltd.
Wen Wensheng
A61K 39/12
Loading...
The invention relates to a method for industrially producing porcine reproductive and respiratory syndrome (PRRS) vaccines by utilizing a bioreactor. The method comprises the following steps: (1) sterilizing a microcarrier and the bioreactor, then adding cell growth liquid, inoculating cells for vaccine preparation for culturing, inoculating PRRS viruses when dense monolayers are formed on the cells on the microcarrier and continuing culturing to reproduce the viruses; (2) stopping culturing and harvesting virus suspension when cytopathy reaches more than 80%; and (3) adding a freeze-drying protective agent to the harvested virus suspension to prepare freeze-dried attenuated live vaccines or carrying out ultrafilter concentration as well as virus inactivation on the harvested virus suspension, purifying the inactivated viruses by adopting column chromatography, and adding adjuvants to prepare inactivated vaccines. Compared with the traditional spinner bottle production process, the method has the following advantages: the automation control degree is high, so production can be monitored in real time; the labour is saved, thus reducing the cost; the land for production is few, thus being easy to enlarge the scale of production; and the produced viruses have high titer, so the batch-to-batch variation is small, the product quality is stable and the side reaction is low.
48. 102038943 Method for industrially producing porcine Japanese encephalitis (JE) vaccines by utilizing bioreactor
CN
04.05.2011
A61K 39/12 Loading...
A61K 39/12
Loading...
201010284021.2
Wuhan Chopper Biology Co., Ltd.
Liu Hanping
A61K 39/12
Loading...
The invention provides a method for industrially producing porcine Japanese encephalitis (JE) vaccines by utilizing a bioreactor. The method comprises the following steps: (1) sterilizing a microcarrier and the bioreactor, then inoculating cells for vaccine preparation for culturing, inoculating JE viruses when dense monolayers are formed on the cells on the microcarrier, and continuing culturing to reproduce the viruses; (2) stopping culturing and harvesting virus suspension when cytopathy reaches more than 80%; (3) carrying out ultrafilter concentration as well as virus inactivation on the harvested virus suspension; and (4) purifying the inactivated viruses by adopting column chromatography to prepare inactivated vaccines. In the method, the technology of using the microcarrier in the bioreactor for culture is adopted to carry out high density culture of the cells to produce the porcine JE vaccines. Compared with the traditional spinner bottle production method, the method has the following advantages: the automatic control degree is high, so production can be monitored in real time; the labour is saved, thus reducing the cost; the land for production is few, thus being easy to enlarge the scale of production; and the produced viruses have high titer, so the batch-to-batch variation is small, the product quality is stable and the side reaction is low.
49. 102038946 Method for industrially producing pseudorabies vaccine by using bioreactor
CN
04.05.2011
A61K 39/245 Loading...
A61K 39/245
Loading...
201010282142.3
Wuhan Chopper Biology Co., Ltd.
Qin Honggang
A61K 39/245
Loading...
The invention relates to a method for industrially producing a pseudorabies vaccine by using a bioreactor. The method comprises the following steps of: (1) sterilizing a microcarrier and the bioreactor, inoculating cells for vaccine production, culturing the cells, and after the cells on the microcarrier form a compact monolayer, inoculating pseudorabies virus, and continuously culturing to allow the virus to reproduce; (2) after more than 80 percent of cells are subjected to a cytopathic effect, stopping culturing, and obtaining virus liquid to prepare the pseudorabies vaccine. In the method, the pseudorabies vaccine is produced by culturing the cells in high density by the bioreactor microcarrier culture technology; and compared with the conventional roller bottle production process, the invention has the advantages that: the method has high automation control degree, saves manpower, reduces cost and is small in production land, the production can be monitored in real time, the scale is easy to expand, the produced virus has high titer and small difference among batches, and the product has stable quality and small side effect.
50. 101936998 Antirabies virus IgG (Immunoglobulin G) antibody ELISA (Enzyme Linked Immunosorbent Assay) detection kit for dogs
CN
05.01.2011
G01N 33/577 Loading...
G01N 33/577
Loading...
201010257527.4
Wuhan Chopper Biology Co., Ltd.
Liao Yuanyuan
G01N 33/577
Loading...
The invention relates to an antirabies virus IgG (Immunoglobulin G) antibody kit for dogs. In the kit, an enzyme label plate is coated with anti-rabies virus monoclonal antibodies in advance, wherein a coating buffer solution is 0.05M of carbonate buffer solution with pH of 9.6, and the coating amount is 0.1-1ug per hole; 1-10% of BSA (Bull Serum Albumin) or skimmed milk in percentage by mass concentration is used as a blocking buffer; rabies virus purified antigens are coated after blocking, wherein the coating amount is 0.1-1ug per hole; 0.01mol/L PBS (Phosphate-Buffered Saline) with pH 7.2-7.4 containing 0.1-10% of BSA and 0.01-0.05% of NaN3 in percentage by mass concentration is used as a sample diluent; a horse radish peroxidase-rabbit anti-rabies IgG enzyme conjugate is used as an enzyme conjugate; 0.01mol/L PBS with pH 7.2-7.4 containing tween-20 with volume concentration of 0.05% is used as a washing concentrate; an enzyme substrate A solution is a 3,3'-5,5'-tetramethyl benzidine solution, and an enzyme substrate B solution is a hydrogen peroxide solution; a 1 mol/L H2SO4 solution is adopted as a stop solution; and a positive control and a negative control are arranged in the kit. With 100% of specificity and 1:640 of sensitivity, the kit is used for the immune effect evaluation of experimental dogs, pet dogs and common dogs which are inoculated with rabies vaccines.
51. 101936997 Human anti-rabies virus IgG antibody ELISA test kit
CN
05.01.2011
G01N 33/577 Loading...
G01N 33/577
Loading...
201010257264.7
Wuhan Chopper Biology Co., Ltd.
Liu Hanping
G01N 33/577
Loading...
The invention relates to a human anti-rabies virus IgG antibody ELISA test kit. An ELISA plate is firstly coated with an anti-rabies virus monoclonal antibody, wherein the coating buffer solution is a 0.05M carbonate buffer solution of which the pH value is 9.6, and the coating amount is 0.1-1ug per hole; a blocking solution is a BSA or skimmed milk of which the mass concentration is 1-10%; the ELISA plate is coated with a rabies virus purified antigen after being blocked, wherein the coating amount is 0.1-1ug per hole; a sample diluent is a 0.01mol/L phosphate buffer solution (PBS) which contains bovine serum albumin (BSA) with a mass concentration of 0.1-10% and NaN3 with a mass concentration of 0.01-0.05 and has a pH value of 7.2-7.4; an enzyme conjugate is a horse radish peroxidase-mouse anti-human IgG enzyme conjugate; a concentrated cleaning solution is a 0.01mol/L PBS which contains tween-20 with a volume concentration of 0.05% and has a pH value of 7.2-7.4; a zymolyte A solution is a 3,3'-5,5'-tetramethyl benzidine solution, and a zymolyte B solution is an oxydol solution; and a stop solution is a 1mol/L H2SO4 solution, and a positive control and a negative control are arranged in the kit. The specificity of the kit is up to 100%, and the sensitivity is 1:640. The kit is used for evaluating the immunity effect of humans inoculated with rabies vaccines.
52. 101930003 Anti-rabies virus IgG antibody colloidal gold immunochromatographic assay reagent plate and preparation method
CN
29.12.2010
G01N 33/569 Loading...
G01N 33/569
Loading...
201010257265.1
Wuhan Chopper Biology Co., Ltd.
Liao Yuanyuan
G01N 33/569
Loading...
The invention relates to an anti-rabies virus IgG antibody colloidal gold immunochromatographic assay reagent plate and a preparation method. Glass fiber paper and cellulose nitrate films are laid on a polyethylene plate and a polyvinyl chloride substrate film; the cellulose nitrate film is coated with an assay line and a contrast line; and a gold-labeled probe polyester film is adhered on the assay line side; water-absorbing filter paper is adhered on the contrast line side, wherein the assay line is coated with rabies virus purified antigen, and the contrast line is coated with anti-SPA purified antigen. The reagent plate of the invention has the advantages of rapid detection, high detection accuracy, high specificity, convenient carrying, simple and convenient operation and can be used for detecting rabies virus antibodies of various animals and human. The assay reagent plate can be stored at the normal temperature for 1 year without special equipment or apparatus and has high assay repeatability.
53. 101829211 Fish compound traditional Chinese medicinal preparation and preparation method thereof
CN
15.09.2010
A61K 36/734 Loading...
A61K 36/734
Loading...
201010162861.1
Wuhan Chopper Fishery Bio-Tech Co., Ltd.
Ai Taoshan
A61K 36/734
Loading...
The invention discloses a fish compound traditional Chinese medicinal preparation prepared from raw materials including rhubarb, acanthopanax, radix astragali, hawthorn and liquorice according a certain weight ratio. A method for preparing fish compound traditional Chinese medicinal preparation comprises the following steps of: A. washing and drying the rhubarb, the acanthopanax, the radix astragali, the hawthorn and the liquorice in the sun; B. respectively crushing and sieving the rhubarb, the acanthopanax, the radix astragali, the hawthorn and the liquorice to ensure the granularity reaches 140-200 mu; and C. weighing up the rhubarb, the acanthopanax, the radix astragali, the hawthorn and the liquorice according to the ratio and mixing and subpackaging after uniformly mixed to obtain the fish compound traditional Chinese medicinal preparation. The method has the advantages of feasibility, convenient operation, reasonable formulation and convenient use; traditional Chinese medicines have wide sources, low price, remarkable effects and no toxic or side effects; various components mutually act; and the invention simultaneously has two properties of nutrition and medicament, not only contains nutrient substances, but also has components with antibacterial activity and other bioactivities, can improve the metabolism of cultivated fishes, promote the growth and the development, improve the immunologic function, prevent and treat diseases and the like.
54. 101603035 Porcine reproductive and respiratory syndrome virus chimeric recombinant vaccine strain and method for producing living vaccine with same
CN
16.12.2009
C12N 7/01 Loading...
C12N 7/01
Loading...
200910062139.8
China Institute of Veterinary Drug Control
Ning Yibao
C12N 7/01
Loading...
The invention relates to a porcine reproductive and respiratory syndrome virus chimeric recombinant vaccine strain and a method for producing living vaccine with same; latter half part of GP2 gene and GP3-GP5 gene of the porcine reproductive and respiratory syndrome virus (PRRSV) classic virus PTK strain, M ferritin, N ferritin and spacer sequences thereof and all nucleotide sequences of 3' non-coding region are all deleted by using reverse genetic manipulation and gene combination technology, then replaced with corresponding gene of Chinese highly pathogenic porcine reproductive and respiratory syndrome variant strain and are recombined to be the chimeric recombinant vaccine strain (PC strain) with the PRRSV classic strain and variant strain genes simultaneously, the chimeric recombinant vaccine PC strain is used to produce the living vaccine which has low toxicity, ensures no returning of strong toxicity within 5 generations of returning swine and the heritability is stable; the invention has good immunogenicity, and can prevent the porcine reproductive and respiratory syndrome virus classic strain and highly pathogenic variant strain from being infected simultaneously.

